Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort.
- DOI
- 10.1016/j.ymgmr.2026.101377
- Published
- 2026 Dec
- Container
- Molecular genetics and metabolism reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymgmr.2026.101377,
title = {Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort.},
author = {Mathew C and Carey N and Losty E and Crushell E and Monavari A and Elsammak M and Carroll A and Knerr I},
year = {2026},
journal = {Molecular genetics and metabolism reports},
doi = {10.1016/j.ymgmr.2026.101377},
url = {https://doi.org/10.1016/j.ymgmr.2026.101377}
}RIS
TY - JOUR TI - Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort. AU - Mathew C AU - Carey N AU - Losty E AU - Crushell E AU - Monavari A AU - Elsammak M AU - Carroll A AU - Knerr I PY - 2026 JO - Molecular genetics and metabolism reports DO - 10.1016/j.ymgmr.2026.101377 UR - https://doi.org/10.1016/j.ymgmr.2026.101377 ER -
APA
C, M., N, C., E, L., E, C., A, M., M, E., A, C., & I, K. (2026). Mucopolysaccharidosis (MPS) type VI: A case series to assess the efficacy of enzyme replacement therapy and to guide precision-based medicine in the IRISH paediatric cohort.. Molecular genetics and metabolism reports. https://doi.org/10.1016/j.ymgmr.2026.101377
Source records
- pubmed · retrieved 2026-11-10T20:44:25.224Z